Apabetalone
A small molecule inhibitor of BET proteins
| Apabetalone | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Apabetalone (also known as RVX-208) is a small molecule that acts as a selective inhibitor of the bromodomain and extra-terminal domain (BET) family of proteins. It is being investigated for its potential therapeutic effects in various cardiovascular and metabolic diseases.
Mechanism of Action[edit | edit source]
Apabetalone functions by inhibiting the activity of BET proteins, which are epigenetic "readers" that recognize acetylated lysine residues on histone tails. This interaction plays a crucial role in the regulation of gene expression. By inhibiting BET proteins, apabetalone modulates the expression of genes involved in inflammation, lipid metabolism, and vascular function.
Therapeutic Applications[edit | edit source]
Apabetalone is primarily being studied for its effects in cardiovascular disease, particularly in patients with atherosclerosis and chronic kidney disease. It has shown potential in reducing the risk of major adverse cardiovascular events (MACE) by modulating inflammatory pathways and improving lipid profiles.
Cardiovascular Disease[edit | edit source]
In clinical trials, apabetalone has demonstrated the ability to reduce levels of C-reactive protein (CRP), a marker of inflammation, and improve high-density lipoprotein (HDL) function. These effects are thought to contribute to its cardiovascular benefits.
Metabolic Disorders[edit | edit source]
Apabetalone is also being explored for its role in managing type 2 diabetes mellitus and related metabolic disorders. By influencing gene expression, it may improve insulin sensitivity and glucose metabolism.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the efficacy and safety of apabetalone. These include studies focusing on its impact on cardiovascular outcomes, renal function, and metabolic parameters in high-risk patient populations.
Safety and Tolerability[edit | edit source]
Apabetalone has been generally well-tolerated in clinical studies, with a safety profile comparable to placebo. Common adverse effects include headache, nasopharyngitis, and gastrointestinal disturbances.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
